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AbstrAct
Kidney transplant patients in our regional centre travel 
long distances to attend routine hospital follow-up 
appointments. Patients incur travel costs and productivity 
losses as well as adverse environmental impacts. A 
significant proportion of these patients, who may not 
require physical examination, could potentially be 
managed through telephone consultations (tele-clinic). We 
adopted a Quality Improvement approach with iterative 
Plan–Do–Study–Act (PDSA) cycles to test the introduction 
of a tele-clinic service. We codesigned the service with 
patients and developed a prototype delivery model that we 
then tested over two PDSA improvement ramps containing 
multiple PDSA cycles to embed the model into routine 
service delivery. Nineteen tele-clinics were held involving 
168 kidney transplant patients (202 tele-consultations). 
2.9% of tele-clinic patients did not attend compared with 
6.9% for face-to-face appointments. Improving both blood 
test quality and availability for the tele-clinic was a major 
focus of activity during the project. Blood test quality 
for tele-clinics improved from 25% to 90.9%. 97.9% 
of survey respondents were satisfied overall with their 
tele-clinic, and 96.9% of the patients would recommend 
this to other patients. The tele-clinic saved 3527 miles of 
motorised travel in total. This equates to a saving of 1035 
kgCO
2. There were no unplanned admissions within 30 
days of the tele-clinic appointment. The service provided 
an immediate saving of £6060 for commissioners due to 
reduced tele-clinic tariff negotiated locally (£30 less than 
face-to-face tariff). The project has shown that tele-clinics 
for kidney transplant patients are deliverable and well 
received by patients with a positive environmental impact 
and modest financial savings. It has the potential to be 
rolled out to other renal centres if a national tele-clinic 
tariff can be negotiated, and an integrated, appropriately 
reimbursed community phlebotomy system can be 
developed to facilitate remote monitoring of patients.
Problem
One in 10 people in England live with chronic 
kidney disease (CKD),1 and around 32 000 
people have a functioning kidney transplant 
in the UK.2 Patients who have had kidney 
transplants need regular specialist moni-
toring commissioned by National Health 
Service (NHS) England.3 This is routinely 
done at face-to-face appointments at approx-
imately 3–4 monthly intervals in 52 regional 
renal centres across England. Each centre 
serves patients from a large geographical 
footprint and so patients routinely travel long 
distances to attend, having an impact on their 
lifestyle, income and environment.
The number of people with a functioning 
kidney transplant is increasing, placing 
heavier demands on renal services and partic-
ularly on outpatient capacity. This will require 
increased funding at a time when the NHS 
is working under unprecedented financial 
constraints. Furthermore, healthcare organi-
sations have a duty to deliver improvements 
in quality, convenience and environmentally 
sustainable service (eg, reduction in CO2 
emissions). For these reasons, there is an 
increasing focus on delivering care closer to 
home.4
North Bristol NHS Trust (NBT) Renal Unit 
covers an area extending to a radius of up 
to 80 miles for kidney transplant patients. 
Therefore, some patients have to travel large 
distances to attend appointments with associ-
ated costs both in terms of travel and produc-
tivity losses, such as time off work or leisure 
activities as well as environmental impacts. A 
significant proportion of these patients have 
stable kidney function but need continued 
specialist monitoring and could potentially 
be managed through telephone consulta-
tions (referred to as ‘tele-clinics’).
The project aimed to establish a tele-clinic 
service for routine monitoring of kidney 
transplant recipients over a 12-month period. 
This was based on patient experience reports 
to the renal unit commenting about diffi-
culties with travel and parking for follow-up 
appointments. A survey of 96 renal transplant 
patients suggested that 59% of patients would 
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consider taking up the option of a tele-clinic appoint-
ment. A detailed semistructured interview of each of the 
11 patients from a pilot tele-clinic in December 2014 was 
undertaken by an evaluator independent of the quality 
improvement team to get patient feedback. The inter-
views were recorded, transcribed and analysed under 
broad themes to inform us of the tele-clinic service model 
and the patients’ perception of the benefits and risks of 
tele-clinics (unpublished). The general consensus was 
that the telephone consultations were a good idea as an 
addition to regular face-to-face appointments. Most of the 
patients suggested that they would be happy to have every 
other appointment as a tele-clinic but would not want all 
their appointments replaced in this way. It was felt that 
they liked the reassurance of being physically ‘seen’ by a 
specialist.
background
Before proceeding with tele-clinics, we conducted system-
atic searches to identify potentially relevant studies that 
supported the safety and acceptability of tele-clinics for 
renal transplant patients and found two non-comparative 
evaluations. A report of 3 years’ experience from one UK 
centre that uses a tele-clinic for kidney transplant recip-
ients concluded that if implemented appropriately, the 
use of tele-clinics for the follow-up of renal transplant 
recipients is safe and confers environmental benefits.5 
However, no formal evaluation of this service has been 
conducted. A systematic review of the use of tele-health 
in nephrology concluded that although tele-health appli-
cations (not restricted to tele-clinics) are currently being 
used successfully in the management of patients with CKD, 
compared with other chronic disease areas, the develop-
ment of tele-health applications appears underused and 
under-researched.6
baseline measuremenT
As we had not used a tele-clinic model before, we agreed 
that our first PDSA cycle would form our improvement 
baseline and a range of comparative measures such as 
attendance and time taken could be used to compare 
performance with the standard delivery model.
We agreed to collect several process measures, outcome 
measures and balancing measures after each tele-clinic 
(table 1). It was recognised that undertaking blood tests 
in the community prior to the tele-clinic appointment 
Table 1 Description of quality improvement project measures
Measure Detail
Process
  Eligible patients who refused to 
participate in tele-clinics
Percentage of patients that were eligible for tele-clinic and approached but refused (and 
reasons why).
  Percentage of patients that did not 
attend
Baseline: percentage of patients that did not attend face-to-face clinics.
Score: percentage of patients that did not attend tele-clinic.
  Blood test result quality Baseline: percentage of correct blood test results for face-to-face clinics.
Score: percentage of correct blood test results for tele-clinics.
  Blood test result availability Baseline: percentage of blood test results available for face-to-face clinics accessed via 
renal Information Technology system or Trust pathology laboratory system.
Score: percentage of blood test results available for tele-clinics accessed via renal IT or 
Trust pathology laboratory system.
  Average minutes per consultation Baseline: allocated time for face-to-face consultations
Score: length of tele-clinic consultations (only time spent on the phone).
Outcome
  Patient experience Overall satisfaction about tele-clinic and proportion of participants who would 
recommend this to other patients.
  Travel miles saved by patients Average miles normally travelled to face-to-face appointments.
  CO2 emissions Miles travelled to face-to face appointments combined with transport used.
Balancing
  Number of unplanned admissions Percentage of patients requiring urgent admission within 1 month of tele-clinic. This 
would potentially measure the safety of tele-clinics and any clinical deterioration that 
was not picked up during the tele-clinic consultation.
  Cost of service Total cost savings per tele-clinic (reduced tariff balanced by number of patients who did 
not attend). We negotiated with specialist commissioners a £30 less tariff for tele-clinics 
compared with face-to-face clinics.
  Inappropriate booking of patients 
into tele-clinic
Number of patients who are not eligible for tele-clinics or those incorrectly booked into 
tele-clinics.
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would improve the effectiveness of the consultation and 
also reduce the need for any further follow-up telephone 
consultations to discuss blood test results. We constructed 
a driver diagram to highlight our working model of the 
key drivers for change and to organise the improvement 
ideas. Our aim was to understand the different processes 
that need to be put in place in the primary–secondary care 
interface to set up the service and also to ensure that the 
blood test results are available to the clinician at the time 
of tele-clinic consultation. The process of undertaking 
blood tests prior to the tele-clinic was a significant depar-
ture from face-to-face appointments where blood tests are 
performed in the clinic, and the results were reviewed 
by the specialist after the clinic. Therefore, we collected 
information from four face-to-face clinics to ascertain 
the baseline percentage of blood test results that are 
available and that correct (appropriate) tests have been 
ordered (96.5%). In part, the project aimed to reduce 
the number of patients not attending their face-to-face 
clinics by offering a tele-clinic option. Therefore, in the 
period August–October 2016, we analysed the number of 
patients who did not attend face-to-face clinic (6.9%).
The allocated time for face-to-face clinic appointment 
currently is 15 min. We anticipated that although tele-
clinic consultation may require less time due to lack of 
need for physical examination, this could be balanced 
out by the lack of visual cues necessitating more in-depth 
questioning and prolonged consultation time during a 
tele-clinic. Therefore, we collected the average length of 
consultation time for tele-clinics but included only time 
spent on the phone for two reasons. First, patients suitable 
for tele-clinics and those who opt to do tele-clinics are less 
likely to be complex clinically compared with face-to-face 
clinic patients and so may require less time for additional 
tasks in clinic such as case notes review or following up 
investigations. Second, additional time may be required 
to chase blood test results for tele-clinic patients if they 
are not accessible on the renal IT system on the day and 
so may not truly reflect the time spent undertaking tele-
phone consultations.
design
This project was codesigned with patients throughout, 
using surveys, semistructured interviews and overarching 
programme governance structures. In addition, two 
patient representatives were active members of the code-
sign team and contributed to the improvement ideas and 
development of the improvement measures and helped 
to operationalise the service through development of 
patient information leaflets and questionnaires. In collab-
oration with West of England Academic Health Sciences 
Network (WEAHSN), we held a multidisciplinary work-
shop in December 2015 with patient representatives, 
renal consultant colleagues, renal administrative team, 
central outpatients booking team, general practitioners 
(GP), transplant nurse specialists, quality improvement 
experts from WEAHSN to process map the potential new 
care pathway for tele-clinics and capture improvement 
ideas (figure 1).
We negotiated a local tariff of £188 compared with 
face-to-face clinic tariff of £218 with NHS England for an 
initial pilot project between August 2016 and July 2017. 
Blood tests were required to be undertaken ahead of the 
tele-clinic at the local GP surgery, but we were unable 
to negotiate a payment to GP surgery with local Clin-
ical Commissioning Groups (CCGs) for this additional 
activity due to lack of engagement from CCGs. However, 
we anticipated that the patient eligibility and demand for 
the tele-clinic service will mean that only 1–2 patients per 
month per GP surgery will require this service and there-
fore should not unduly burden the local phlebotomy 
services at the GP surgery. The project lead, through close 
liaison and through newsletters to GP groups and medical 
committees was able to raise awareness and secure buy-in 
to undertake blood tests for the project.
The tele-clinic intervention was designed to have the 
following main features:
 ► Patients judged suitable for tele-clinics by their 
specialist would be offered a telephone clinic appoint-
ment during which their progress, symptoms, blood 
test results and blood pressure (BP) measurements 
would be discussed and advice given. Patient eligi-
bility criteria were developed by renal consultants 
at NBT based on the consensus that stable patients 
were unlikely to require physical examination or close 
monitoring in secondary care more frequently than 
every 3–4 months. For this pilot, we selected stable 
kidney transplant recipients who had a functioning 
kidney transplant for at least a year; had not had any 
transplant rejection episodes; had not started any new 
immunosuppression medications in the preceding 6 
months; had a rate of decline in glomerular filtration 
rate that was <5 mL/min/1.73 m2/year; had agreed to 
alternate tele-clinics and face-to-face clinics; and did 
not have hearing or learning difficulties that could 
affect telephone consultation.
 ► Patients were invited to opt-in during routine face-to-
face clinic appointments. We created an electronic flag 
on our renal IT system to identify those who refused 
the offer and the reasons for not taking up the offer. 
Those who chose to do tele-clinics were booked in to a 
tele-clinic as the next follow-up appointment.
 ► The tele-clinic would be offered to patients on an 
alternating basis with their face-to-face appointment 
based on feedback received from the qualitative inter-
view from a pilot clinic as described above.
 ► These patients would be sent an appointment invita-
tion letter with instructions to get blood tests done 
ahead of the tele-clinic and encouraged to measure 
BP either at home (self- monitoring through auto-
mated BP devices) or at their GP surgery. After several 
deliberations with the laboratory teams and GPs, it 
was agreed that a blood test form with instructions on 
what blood samples and what tubes the blood samples 
needed to be sent in would be incorporated in the 
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clinic appointment letter. Some of these blood tests 
were standard for all patients, and they were prese-
lected on the form. As different patients were on 
different immunosuppression medications for their 
kidney transplant, measurements of immunosuppres-
sion drug level were not preselected but required 
patients or the phlebotomists at GP surgery to select 
them at the time of sampling. We also created a 
unique location code ‘NBTRT’ to inform the labora-
tories that the samples originated in primary care in 
relation to tele-clinics undertaken by NBT.
 ► We agreed a standard operating procedure with all 
seven pathology labs in the region (NBT; University 
Hospital, Bristol [UHB]; Royal United Hospitals, Bath 
[RUH]; Musgrove Park Hospital, Taunton; Yeovil 
District Hospital, Yeovil; Weston General Hospital, 
Weston; and Gloucestershire Royal Hospital, 
Gloucester) so that results from samples with this 
location code were forwarded to NBT renal team 
rather than to GPs to ensure that these results were 
adequately acted on and to reduce additional work-
load for GPs in dealing with any abnormal results. The 
clinical laboratory systems in NBT, UHB, RUH and 
Weston are electronically linked to the renal IT system 
and results were automatically downloaded. Those in 
Yeovil, Taunton and Gloucester were not electroni-
cally linked and therefore relied on paper copies of 
results to be forwarded to renal unit to be manually 
entered by the renal administration team.
 ► Initially, the telephone clinics were delivered by one 
consultant, but this was rolled out to six consultants 
delivering tele-clinics by the end of the project.
Patient and public involvement (PPi)
We describe the involvement of patients in this project 
according to the GRIPP2 (Guidance for Reporting 
Involvement of Patients and the Public)short-form recom-
mendations for reporting PPI involvement in research.7 
Overall, patients contributed to the project in three 
main ways: (1) exploration of patient need and proof of 
concept for the clinic, (2) patient feedback and input 
into the improvement cycles and (3) project governance.
Exploration of need and proof of concept
Patients were initially involved in this project to under-
stand their current experience of the service and to 
better understand the impact that travelling to an outpa-
tient appointment had on their lives. This was under-
taken to ensure that the project focused on improving 
patient experience and improving people’s lives. To 
Figure 1 Process map for tele-clinics. GP, general practitioner; NBT, North Bristol NHS Trust.
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do this, we undertook an initial paper-based survey of 
96 patients. We undertook a more detailed semistruc-
tured interview of 11 of the participating patients from 
the pilot tele-clinics (as described in the background 
section). These interviews generated very rich data and 
helped to demonstrate to service managers and commis-
sioners that patients were articulating a need for such 
a service and preferred the flexibility of this compared 
with the normal service model. This feedback helped to 
refine the improvement ideas generated in the workshop 
and refine the methodology of the PDSA cycles for the 
tele-clinic.
Patient feedback and input into the improvement cycles
We recruited two kidney transplant recipients to our 
project from our existing patient panel who were involved 
in other research and service development projects at our 
centre. These two patient members participated in the 
initial workshop (as described above) and contributed to 
the development of the driver diagram, articulating the 
patient’s perspectives and generating improvement ideas. 
They made a significant contribution to the development 
of the quality improvement project measures using lived 
experience to test the relevance of the process, outcome 
and balancing measures.
They supported the design of the patient informa-
tion leaflet and the tele-clinic appointment letter, 
checking that all the instructions to record home BP 
and undertake blood tests in primary care were relevant 
and easy to understand. They provided feedback and 
contributed to the development of the patient satisfac-
tion questionnaire that was administered to all patients 
participating in the tele-clinics. They also provided 
further input to revising the content of the tele-clinic 
appointment letter with instructions based on feedback 
received from other patients through the patient satis-
faction questionnaire.
The two patient members were invited to coauthor this 
report but declined.
Project governance
Patients were also included in the governance of the 
programme through Bristol Health Partners, working in 
partnership with People in Health West of England ( www. 
phwe. org. uk).
People in Health West of England is an innovative PPI 
collaborative that brings together patient experience 
across a range of organisations striving to undertake 
transformational change and research.
Progress on the project was discussed with the core 
patient members at regular steering group meetings 
under the auspices of the Bristol Health Partners Board.
sTraTegy
This project had two parallel PDSA improvement ramps, 
with multiple PDSAs contained within each.
Pdsa improvement ramp 1: close management of tele-clinic 
set up
As patients had the choice of opting in for the tele-clinics, 
it was difficult to predict the demand for the service. 
We, therefore, decided to set up the clinic as and when 
required depending on the demand. Patients were added 
on to the waiting list on the patients booking system, and 
a clinic was created as required. Between August 2016 
and December 2016, our first improvement ramp tested 
close management of these processes required to deliver 
tele-clinics. The PDSA tests included:
 ► Appointment bookings carried out by renal access 
coordinator.
 ► Specialist transplant nurse having regular engage-
ment with patients to ensure that they had conducted 
blood tests and BP monitoring.
 ► One consultant undertaking the tele-clinic at a 
frequency of one a month.
 ► Throughout the pilot, we measured how many 
patients’ blood test results had been produced 
correctly. Our criterion for a ‘correct’ result was one 
that included all tests including immunosuppres-
sion drug levels requested. As the blood test results 
were conducted in primary care (rather than being 
done at Southmead Hospital), there was reliance 
on both the patient and the professional taking the 
blood test to follow the instructions in the appoint-
ment letter. As this was new for primary care profes-
sionals and patients, the project team conducted 
several PDSA cycles to improve the instructions to 
GP surgery on blood test form within the appoint-
ment letter to undertake blood tests. This was based 
on feedback from patients and discussions with 
GP surgery where blood tests were not performed 
correctly as required.
 ► For the tele-clinics to be viable, it was essential for 
the specialists to be able to see the blood test results 
during the consultation. This relied on pathology 
laboratories around the region being sufficiently well 
linked to NBT’s IT systems for results from samples 
sent by GP surgery to appear in time for the tele-clinic. 
There was close liaison with regional laboratories 
that were not electronically linked to NBT to ensure 
that blood test results were forwarded appropriately 
to the renal unit. A result was defined as ‘available’ 
if it was available through the renal IT system or the 
NBT Clinical Laboratory system. The clinician could 
still access results that were not visible on the renal IT 
system by calling the local laboratories. However, this 
required additional time spent during the tele-clinic 
chasing the results.
Pdsa improvement ramp 2: embedding tele-clinic service
Between January 2017 and July 2017, our second improve-
ment ramp tested a more distributed model of managing 
tele-clinic service. Main PDSA cycles included testing:
 ► Additional consultants conducting tele-clinics. A 
second consultant contributed to tele-clinics from 
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January 2017 to March 2017, and four additional 
consultants joined in from April 2017.
 ► Frequency of clinics increased to two per month.
 ► Bookings done by NBT Outpatients Central bookings 
team.
 ► Medical secretaries ensuring that blood test results 
were available on renal IT system 48 hours before tele-
clinic and contacting the local laboratories for results 
if required.
resulTs
Patients signing up to tele-clinics
In total, we initially approached 389 eligible kidney trans-
plant patients. Of these, 185 (47.6%) agreed to take part. 
The most frequent reasons given for declining to take 
part were: preferring face-to-face interaction and not 
having issues with accessing the hospital for face-to-face 
appointments. Table 2 summarises the reasons why the 
remaining 52.4% patients declined signing up to tele-
clinics.
Percentage of patients that did not attend
A percentage of 2.9 (n=6) of tele-clinic patients did not 
attend their tele-clinic appointment compared with 6.9% 
for face-to-face clinics between August 2016 and October 
2016. Reasons for non-attendance at tele-clinics were 
investigated and were explained by individual factors (eg, 
patient that regularly did not attend face-to-face clinics, 
also did not attend tele-clinic) rather than being linked 
to any features of the intervention or the changes intro-
duced and tested through PDSA cycles.
Table 2 Reasons for patients not taking up tele-clinics
Reason for not participating Number Percentage
Prefer face-to-face interaction 76 37.3
No response 66 32.6
Accessing hospital is not an issue 48 23.6
Unsure they could arrange blood 
tests
7 3.5
General practitioner refused to do 
blood tests
6 2.9
Unsure they could arrange blood 
pressure readings
1 0.04
Table 3 Summary of PDSA cycles to improve blood test quality
PDSA description
Blood test quality 
(average per cent 
conducted correctly in 
PDSA period)
PDSA 1:
Sending the appointment letter with <2 weeks’ notice to arrange blood tests
(July–August 2016)
25
PDSA 2: increasing the notice to 4 weeks
(September–October 2016)
90.5
PDSA 3:
Amendments to the appointment letter to make it clearer what the patient needed to request and 
the levels to be taken. Patient feedback also suggested that patients found the number of blood 
pressure readings requested were excessive. Based on this, the requirement for BP readings was 
reduced.
(November–December 2016)
90
PDSA 4:
Declines in blood test availability below the control limit prompted further changes to the 
appointment letter. These changes included: noting that it was essential for the form to be used 
and kept safe by the patient and improved checkbox layout. This coincided with the clinic roll-out 
to other consultants and the booking process been managed by the central booking team. The 
transplant nurse specialist also ceased to individually call patients to ensure that the correct blood 
tests were done. Patient feedback and liaison with local laboratories clarified that this was due to 
blood test forms being filled out incorrectly. (January–February 2017)
64.5
PDSA 5:
Amendments in PDSA 4 did not yield sufficient improvements to blood test quality. Therefore, 
the appointment letter changed to take a different approach—with very clear ‘step-by-step’ 
instructions for both patients and primary care staff.
The initial impact of this change was unclear. Blood test quality went above and below control 
limit for the first six tele-clinics. The final four tele-clinics all saw quality levels above the control 
limit.
(March–July 2017)
84.5
PDSA, Plan–Do–Study–Act.
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blood test quality
During the pilot, overall 74.8% of blood tests were 
ordered correctly. Table 3 shows the proportion of blood 
tests undertaken correctly in the different time periods. 
The blood test quality in the final PDSA cycle was 90.9% 
(figure 2). This is slightly lower than the figure for face-to-
face clinics (96.5%). Unlike the face-to-face clinic, where 
blood tests are done by few trained renal phlebotomists, 
blood tests are undertaken by multiple staff members 
within several GP practices. We acknowledged the 
inherent limitations in this model and accepted that the 
blood test quality for tele-clinics is unlikely to match that 
for face- to-face clinic results. The results that were often 
missed or incorrectly done were the immunosuppression 
drug levels. A missing single immunosuppression drug 
level does not adversely affect clinical decision making 
as we mostly rely on trends in immunosuppression drug 
levels to adjust dosing. Follow-up of these patients with 
missing results in subsequent face-to-face clinics did not 
identify any adverse events relating to incorrect results.
blood test availability
At the start of the project, results from all laboratories 
in NBT, UHB, RUH and Weston were accessible through 
renal IT system. Towards the end of the QIP (Quality 
Improvement Project) in July 2017, we were able to get 
the remaining laboratories in Taunton and Yeovil, elec-
tronically connected, and results were automatically 
downloaded onto the renal IT system. Gloucester was still 
not electronically linked, and we relied on paper copies 
of results to be sent to us. The main reasons for results 
not being visible were: blood test forms (with location 
code NBTRT) not accompanying the samples sent by GP 
surgery. Instead locally generated labels used by primary 
care staff on blood samples and therefore results 
forwarded back to GPs and not to renal unit. There was 
a lack of awareness of protocol for processing results 
accompanied by blood test form with NBTRT location 
code among some laboratory staff. On average, 84.4% of 
blood test results were available for the tele-clinics during 
the entire project but the final PDSA cycle showed an 
improvement to 90.9% (figure 3).
length of tele-clinics
Across all tele-clinics, the average call length was 10.3 min 
(figure 4). The figures from January 2017 are an average 
for all consultants who have done the tele-clinic. There is 
a trend towards reduced length of consultation time over 
the course of the project. This could be due to the fact 
that clinicians became more familiar with the conduct of 
the tele-clinic. We also had developed a standard tele-clinic 
template, which was used by clinicians as an aide memoire 
during the consultation process. The spike observed in 
April 2017 was associated with another consultant colleague 
undertaking the tele-clinic for the first time.
Patient experience
There were 97 responses to the patient satisfaction survey 
(57.7% response rate). Surveys were sent by post and 
through the Survey Monkey website. A summary of find-
ings is presented in table 4. A rating of ‘6’ is the highest 
level of satisfaction, while ‘1’ is the lowest. The ‘0’ was 
chosen by a small number of patients when a statement 
was not relevant (eg, if they had not been able to arrange 
Figure 2 Run chart showing blood test quality. PDSA, Plan–Do–Study–Act.
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a blood test). A percentage of 97.9 of respondents were 
satisfied overall with their tele-clinic. Positive comments 
about the experience focused on the quality of the conver-
sation itself and the convenience of conducting the clinic 
by phone. More negative comments tended to focus on 
what might be lost through telephone interaction rather 
than face-to-face sessions or specific comments about 
challenges in arranging blood tests.
Figure 3 Run chart showing blood test availability. PDSA, Plan–Do–Study–Act.
Figure 4 Run chart showing average length of call during each tele-clinic.
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estimated reduction in co2 emissions
Among those who responded to the survey, the average 
distance normally travelled by patients to their face-to-
face appointments was 36.4 miles. The tele-clinic saved 
3527 miles of motorised travel in total. This equates to 
a saving of 1035kgCO2.
8 The actual reduction in travel 
distance and CO2 emissions will be much higher than this 
given that the response rate to patient survey was only 
57.7%.
Patients requiring urgent follow-up within 1 month tele-clinic
This measure was in place to ensure the safety of the tele-
clinics. There were no unplanned admissions to hospital 
or urgent follow-up outpatient visits at NBT for the 
patients taking part in the tele-clinics. However, we do not 
have data to verify if the tele-clinic patients had required 
additional visits to their GPs that may not have been 
required if they had been seen in a face-to-face clinic.
cost of service
The tariff for tele-clinics was £188; this is £30 less than the 
standard face-to-face rate of £218. The service provided 
an immediate saving to commissioners of £6060, but this 
excludes the blood sampling costs in primary care. Gener-
ating a definitive estimate of cost saving for the tele-clinic 
project has proved challenging due to the way that activity 
and costs are recorded in secondary care. Isolating the 
total specific costs for a face-to-face clinic versus a tele-
clinic has not been possible. This would be a valuable area 
for future research.
inappropriate patients booked into tele-clinic
We have been testing whether patients who do not meet 
the eligibility criteria have been booked into tele-clinics. 
In total, three inappropriate patients were booked into 
the tele-clinics. One patient was diagnosed with dementia 
and so was no longer eligible. One patient was due to a 
booking error and had been seen for a face-to-face clinic 
the week before. One was a patient that regularly did not 
attend face-to-face clinic appointments and did not pick 
up their phone call.
lessons and limiTaTions
PPI involvement was crucial to ensure that the new 
service being offered was fit for purpose as this was 
intended to improve patient experience. The semistruc-
tured interviews highlighted the importance of offering 
patients the choice to opt-in for tele-clinics and to main-
tain some of the appointments as face-to-face visits and 
hence the provision of alternating tele-clinics and face-
to-face appointments. The patient members within the 
quality improvement team were kidney transplant recip-
ients themselves attending face-to-face appointments at 
our centre and therefore provided valuable insight in 
codesigning the service, logistics of undertaking blood 
tests in primary care and the use of language that was 
understood by patients with kidney disease in the clinic 
appointment letter and patient information leaflet. In 
addition to the experienced patient members’ input in 
to the project, we found the feedback that we collected 
through our satisfaction survey informative and 
provided us a broader perspective of other patients’ 
experiences.
The success of the tele-clinics relied heavily on primary 
care’s willingness to conduct blood tests without a 
formal agreement for these costs to be reimbursed. Due 
to the small volume of patients per practice needing 
this service, it was possible to sustain this for the pilot. 
However, six GP practices decided not to support the 
pilot due to the lack of reimbursement. While efforts 
were made to explain the purpose and benefits of the 
pilot, we have not been able to engage with CCGs and 
GP surgery due to sustainability transformation plan 
reconfiguration and other competing priorities for the 
CCGs. Addressing this issue will be essential for the 
service to become embedded and sustainable long term 
as without consistent GP support, the service will inevi-
tably lead to health inequalities.
We anticipated higher demand for tele-clinics (59%) 
based on patient survey than observed for this project 
(47.5%). This figure, gathered through this project, 
draws on a larger number of patients and can be 
used for more accurate planning of future tele-clinic 
services. We have also identified the reasons for patients 
declining tele-clinics. This gives a platform for future 
attempts to recruit suitable patients to tele-clinics.
Table 4 Summary of patient ratings of the tele-clinic service
Rating score
Percentage of respondents by rating
6 5 4 3 2 1 0
Patient information sheet on tele-clinic service 64.9 25.8 6.2 2.1 0.0 0.0 0.0
Information in advance: blood pressure and samples in the appointment 
letter
53.6 27.8 11.3 5.2 0.0 0.0 2.1
Ease of getting blood test 53.6 20.6 15.5 6.2 2.1 0.0 1.0
Ease of getting blood pressure recording 73.2 10.3 8.2 3.1 0.0 0.0 1.0
Overall satisfaction 71.1 20.6 6.2 1.0 0.0 1.0 0.0
Would you recommend this to another patient? 77.3 16.5 3.1 2.1 0.0 0.0 0.0
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While we have been able to identify several financial 
and efficiency benefits arising from the project, we have 
not been able to produce a definitive picture of the cost 
of tele-clinics versus face-to-face clinics. Collaboration 
with health economists might help to address this gap. 
In addition, while we failed to find any evidence that tele-
clinics were associated with increased 30-day hospital 
admission or urgent follow-up visits in secondary care, 
this quality improvement project was never powered to 
detect such a difference. A much larger study, ideally 
a randomised controlled trial, would be required to 
provide far more definitive evidence of safety or equiva-
lence between the two modes of delivery.
In addition, we were not able to collect data on addi-
tional GP consultations in-between the tele or face-to-face 
clinics. It is possible that a face-to-face clinic may detect 
early problems and deal with them thereby reducing future 
GP workload. However, it is also possible that face-to-face 
consultations generate more workload for GPs than tele-
clinics. This requires further evaluation.
conclusions
The project has shown that tele-clinics for kidney trans-
plant patients are deliverable and well received by patients 
with a positive environmental impact. The project has also 
delivered modest financial savings for the NHS; however, 
the true financial picture for the wider health economy 
and the health economic benefits for patients and the 
environment has been hard to capture and would warrant 
further research. This model has the potential to be rolled 
out to other renal centres if a national tele-clinic tariff that 
is acceptable to all stakeholders can be negotiated, and 
an integrated and appropriately reimbursed phlebotomy 
service can be developed to facilitate remote monitoring of 
patients between primary and secondary care.
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